Engineers Gate Manager »

Galectin Therapeutics shares owned by Engineers Gate Manager

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Engineers Gate Manager from 13F filings

Historical chart of Engineers Gate Manager investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Engineers Gate Manager consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Engineers Gate Manager

Quarter filed Position value Share count Share price at filing
2026-03-31 $52k 19k 2.79
2024-12-31 $21k 17k 1.29

More positions owned by Engineers Gate Manager

Metropcs Communications (TMUS)
General Motors Company (GM)
Black Hills Corporation (BKH)
Microsoft Corporation (MSFT)
Mastercard Incorporated Cl A (MA)
Parker-Hannifin Corporation (PH)
Phillips Edison & Co Common Stock (PECO)
Sba Communications Corp Cl A (SBAC)
Aramark Hldgs (ARMK)
Itt (ITT)
Ventas (VTR)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
First Industrial Realty Trust (FR)
Citizens Financial (CFG)
Darling International (DAR)

View all positions for Engineers Gate Manager

Top funds holding Galectin Therapeutics

Vanguard Capital Management
Marshall Wace
Advisor Group Holdings
Susquehanna International
Dr. Jeffrey R. Jay, M.D.
BlackRock
Millennium Management
Sontag Advisory
Geode Capital Management
Two Sigma Investments
Commonwealth Equity Services
Citadel Advisors
Jane Street
Vanguard Fiduciary Trust
LPL Financial

View all funds holding Galectin Therapeutics